Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ESALY

Recent news which mentions ESALY

< Previous 1 2 3 4 5 Next >
Amazon Considers Launching Ad-Supported Prime Video Tier, Google & Microsoft Face Backlash For Ad Inclusion In AI Trials, Airbus Records One-Third Jump In May Deliveries: Today's Top Stories
Tickers AMZN BLK DIS EADSY
Tags SPY BLK MSFT
From Benzinga
FDA Signals Support for Eisai-Biogen Alzheimer's Drug Data Confirms Benefits For Complete Approval
Tickers BIIB ESALF ESALY
Tags Health Care BIIB Biotech
From Benzinga
Medtronic, Merck, Williams Companies And More: CNBC's 'Final Trades'
Tickers ESALY IEF MDT MRK
Tags Jenny Harrington MDT Media
From Benzinga
After Back To Back Failure For Keytruda Plus Lenvima, Merck Touts Durable Clinical Benefit For The Combo In Advanced Kidney Cancer
Tickers ESALY MRK PFE
Tags Market News MRK Benzinga
From Benzinga
Analysts Say Eli Lilly's Donanemab In Alzheimer's Is Encouraging, Outline Potential Implications For Biogen
Tickers BIIB ESALF ESALY LLY
Tags Market News Analyst Ratings Benzinga
From Benzinga
Will US Medicare Fully Cover Alzheimer's Drugs? Eli Lilly Thinks Yes!
Tickers BIIB ESALF ESALY LLY
Tags ESALY Briefs News
From Benzinga
Merck, Eisai Shelve Keytruda Plus Lenvima Combo Trial In Skin Cancer Setting, Disappoints In Certain Type Of Colorectal Cancer
Tickers ESALF ESALY MRK
Tags General Briefs News
From Benzinga
Tesla Manufactured 4,000 Model Ys In One Week, UBS Prepping For Massive Layoffs, McDonald's Temporary Shuttering Of US Offices: Today's Top Stories
Tickers ATVI BIIB BOXD CS
Tags M&A General Legal
From Benzinga
National Institute on Aging Aims Building $300M Alzheimer's Research Database
Tickers BIIB ESALF ESALY
Tags Benzinga Alzheimer’s Market News
From Benzinga
Eisai-Biogen Highlights Additional Data From Recently Approved Alzheimer's Drug
Tickers BIIB ESALF ESALY
Tags Benzinga ESALF Market News
From Benzinga
7 Healthcare Stocks to Buy for Long-Term Growth and Stability
Tickers BIIB ESALY HRMY INCY
Tags ESALY INCY HRMY
From InvestorPlace
Alzheimer's Association Launches Grassroots Level Lobbying For Medicare Coverage Of Alzheimer's Treatments
Tickers BIIB ESALF ESALY LLY
Tags General Government News
From Benzinga
Analyst Says Biogen-Eisai's Alzheimer's Treatment Leqembi Coverage Enables Access To Over $2.5B Market Opportunity
Tickers BIIB ESALF ESALY
Tags Market News Benzinga Biotech
From Benzinga
Eisai-Biogen Seek Complete FDA Approval For Its Second Alzheimer's Treatment
Tickers BIIB ESALF ESALY
Tags ESALY Briefs News
From Benzinga
Why Anavex Life Sciences Stock Bolted Higher in January
Tickers AVXL BIIB ESALY
Tags AVXL BIIB Recent Press Releases
From Motley Fool
February PDUFA Catalysts Biotech Investors Must Know: Sanofi's Bleeding Disorder Drug, Regeneron's Twin Eylea Label Expansions, 3 Delayed Approvals And More
Tickers APLS BIIB CYTK EBS
Tags LGND SNY General
From Benzinga
Is Biogen Stock a No-Brainer Buy After Eli Lilly's Alzheimer's Disease Setback?
Tickers BIIB ESALY LLY
Tags ESALY Market News BIIB
From Motley Fool
Why Biogen's Stock Isn't Soaring Since Its Alzheimer's Drug Got Approval
Tickers BIIB ESALY
Tags Market News ESALY BIIB
From Motley Fool
This Monumental Breakthrough Could Turn the World Upside Down -- and Make Some Investors Filthy Rich
Tickers ABBV BIIB ESALY GOOG
Tags Market News GOOGL UNH
From Motley Fool
Should You Buy Biogen Stock After Its Latest Alzheimer's Disease Drug Approval?
Tickers BIIB ESALY
Tags Market News ESALY BIIB
From Motley Fool
Barron's Top Weekend Stock Picks: Tesla, Snowflake, Delta And Why Warren Buffett's Berkshire Hathaway May Be In For Big Tax Bill
Tickers BIIB BRK-A BRK-B DAL
Tags ROKU ZM DAL
From Benzinga
FDA approves treatment for people with mild forms of Alzheimer’s
Tickers BIIB ESALY SPX
Tags ESALY SPX BIIB
From MarketWatch
FDA Approves Biogen's Second Alzheimer's Treatment Under Accelerated Pathway
Tickers BIIB ESALF ESALY
Tags ESALF Briefs why it's moving
From Benzinga
Lecanemab Alert: What Would Alzheimer’s Drug Approval Mean for Biogen (BIIB) Stock?
Tickers BIIB ESALY
Tags Market News ESALY Today's Market
From InvestorPlace
1 Stock Defying the Downturn to Buy, and 1 to Avoid
Tickers AZN BIIB ESALY
Tags Recent Press Releases BIIB AZN
From Motley Fool
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
Tickers BGNE BIIB CDTX CHRS
Tags Biotech Small Cap CHRS
From Benzinga
1 Green Flag and 1 Red Flag for Biogen
Tickers BIIB ESALY
Tags Recent Press Releases BIIB ESALY
From Motley Fool
Biogen's Alzheimer's Antibody Might Have A Third Death Associated With
Tickers BIIB ESALF ESALY
Tags ESALF News Briefs
From Benzinga
Catalyst Pharma Acquires US Rights To Eisai's Epilepsy Drug
Tickers CPRX ESALF ESALY
Tags ESALF ESALY Movers
From Benzinga
The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond
Tickers BIIB BNTX ESALY INCY
Tags VTRS VEEV INCY
From InvestorPlace
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.